Drug Trial News

RSS

People in their mid-60s are more vulnerable to memory-related scams

Especially if you're older, get everything in writing, from estimates to receipts. Psychologists at Washington University report that the memory function of people in their mid-60s and up is easily swayed by the power of suggestion, making them more vulnerable to memory-related scams.

16 May 2005

Study shows the longest reported survival rate for patients with locally advanced lung cancer

Five-year data from a study evaluating the use of docetaxel (Taxotere) administered after cisplatin/etoposide chemotherapy plus radiation therapy demonstrate the best long-term survival rates reported in patients with locally advanced (Stage IIIB) non-small cell lung cancer (NSCLC).

16 May 2005

Women more vulnerable to chronic drinking than men are

A study in the May issue of Alcoholism: Clinical & Experimental Research addresses this gap in research, using computed tomography (CT) to examine brain atrophy in the brains of alcoholic men and women. The findings support and build upon a prior hypothesis that women develop alcohol-related brain damage more readily than men.

16 May 2005

Social anxiety disorder patients may be avoiding their doctor

Patients with social anxiety disorder are less likely to visit their primary care doctors than people with other psychiatric disorders like depression, or patients without mental health disorders, according to new research in the journal General Hospital Psychiatry.

16 May 2005

Primary care clinics at Veterans Affairs hospitals are not recognizing posttraumatic stress disorder

The study, conducted Dr. Kathryn M. Magruder and colleagues, showed that the clinics examined recognized less than half (46.5 percent) the PTSD cases identified by the researchers.

16 May 2005

Genetic biomarker that may improve quality of life during treatment for colorectal cancer

A Mayo Clinic-led study has revealed a genetic biomarker that can predict which patients are most likely to experience unwanted side effects from one of the most commonly used and highly effective chemotherapy regimens designed to treat colorectal cancer.

16 May 2005

Taxotere shows significant survival benefit in the treatment of advanced gastric cancer

Final results from the largest international study in the treatment of advanced stomach cancer, also known as gastric cancer, demonstrated that patients who received a Taxotere (docetaxel) Injection Concentrate-based chemotherapy regimen (Taxotere, cisplatin and 5-fluorouracil) had significantly improved overall survival rates compared to patients who received a standard treatment (cisplatin and 5- fluorouracil).

16 May 2005

Zometa reduces bone loss in patients receiving breast cancer treatment

Data presented at the American Society of Clinical Oncology (ASCO) annual meeting in Orlando, Florida, demonstrate that Zometa (zoledronic acid), an intravenous bisphosphonate, was shown to inhibit bone loss in postmenopausal women treated with Femara (letrozole) in the adjuvant breast cancer setting (directly following surgery to prevent cancer recurrence).

16 May 2005

Alcohol consumption increases movement of S. pneumoniae toward the lungs

Streptococcus pneumoniae is a bacterium that can infect the upper respiratory tract and cause pneumonia, as well as infections in other parts of the body such as the bloodstream (bacteremia), lining of the brain and spinal cord (meningitis), bones (osteomyelitis), joints (arthritis), ears (otitis media) and sinuses (sinusitis).

15 May 2005

Breast cancer hormone drug might help prevent prostate cancer

A hormonal drug used to fight breast cancer might help prevent abnormal prostate growths from turning into cancers.

15 May 2005

Bevacizumab plus chemo extends survival beyond one year for large group of advanced lung cancer patients

Patients with a particular type of advanced lung cancer may have a new option based on data presented at the 2005 annual meeting of the American Society of Clinical Oncology showing that combining a drug that cuts off the cancer's blood supply with standard chemotherapy can shrink tumors and extend life.

15 May 2005

Sensory intervention cab help ADHD kids

Preliminary findings from a study of children with attention deficit hyperactivity disorder (ADHD) show that sensory intervention - for example, deep pressure and strenuous exercise - can significantly improve problem behaviors such as restlessness, impulsivity and hyperactivity. Of the children receiving occupational therapy, 95 percent improved. This is the first study of this size on sensory intervention for ADHD.

15 May 2005

Tamoxifen study counters hopes that drug might protect the heart

Despite previous studies hinting at tamoxifen's potential benefit for breast cancer survivors' heart health, California researchers have found that the breast cancer drug does not decrease survivors' risk of heart attack.

15 May 2005

New anticancer drug SU11248 shows continued response for patients with late-stage kidney cancer

Recent studies of a new anticancer drug show continued response for patients with late-stage kidney cancer. Robert Motzer, MD, attending physician at Memorial Sloan-Kettering Cancer Center (MSKCC), reported a response rate of 40 percent in patients with metastatic (advanced) renal cell (kidney) cancer who received SU11248 in second-line therapy.

15 May 2005

Hospitalizations at children's hospitals account for only one-third of pediatric patients

A study comparing U.S. pediatric hospitalizations showed that only one-third of a total 1.7 million hospitalizations in the year 2000 were to children's hospitals with specialized pediatric expertise. The results were presented today by University of Vermont Professor of Pediatrics Richard Wasserman, M.D., at the 2005 Pediatric Academic Societies' Annual Meeting.

15 May 2005

Doctors and patients think differently about clinical trials

A survey of patients and physicians regarding clinical trials shows that doctors don't recognize the importance of side effects as a barrier for their patients in deciding about whether to undergo experimental therapy.

15 May 2005

Hispanics have worse lung cancer survival rate

In a national population-based study of 16,036 lung cancer patients, Hispanics with curable stage I lung cancer had poorer lung cancer specific survival rates, as well as worse all-cause mortality, than a much larger group of white persons. Study results will appear in the second issue for May 2005 of the American Thoracic Society's peer-reviewed American Journal of Respiratory and Critical Care Medicine.

15 May 2005

First advance in pancreatic cancer treatment in a decade offers new hope

The first advance in pancreatic cancer treatment in a decade has been achieved by researchers in a Canadian-led study, and at last gives some encouragement to scientists and invigorates a field that has experienced more than its share of disheartening failures.

15 May 2005

Neighbourhoods with more fast food outlets are also neighbourhoods with more heart disease

A new study has found that neighbourhoods with more fast food outlets are also neighbourhoods with more heart disease and death, and, it has nothing to do with how rich or poor a neighbourhood might be.

15 May 2005

New treatment for retained placenta

An important new study has been launched by the University of Liverpool and Liverpool Women’s Hospital (LWH), to test a new treatment for ‘retained placenta’- a condition where the placenta does not come out naturally after childbirth.

12 May 2005

Drug Trial News

People in their mid-60s are more vulnerable to memory-related scams

Study shows the longest reported survival rate for patients with locally advanced lung cancer

Women more vulnerable to chronic drinking than men are

Social anxiety disorder patients may be avoiding their doctor

Primary care clinics at Veterans Affairs hospitals are not recognizing posttraumatic stress disorder

Genetic biomarker that may improve quality of life during treatment for colorectal cancer

Taxotere shows significant survival benefit in the treatment of advanced gastric cancer

Zometa reduces bone loss in patients receiving breast cancer treatment

Alcohol consumption increases movement of S. pneumoniae toward the lungs

Breast cancer hormone drug might help prevent prostate cancer

Bevacizumab plus chemo extends survival beyond one year for large group of advanced lung cancer patients

Sensory intervention cab help ADHD kids

Tamoxifen study counters hopes that drug might protect the heart

New anticancer drug SU11248 shows continued response for patients with late-stage kidney cancer

Hospitalizations at children's hospitals account for only one-third of pediatric patients

Doctors and patients think differently about clinical trials

Hispanics have worse lung cancer survival rate

First advance in pancreatic cancer treatment in a decade offers new hope

Neighbourhoods with more fast food outlets are also neighbourhoods with more heart disease

New treatment for retained placenta

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News